| Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts Y Kokai, JN Myers, T Wada, VI Brown, CM LeVea, JG Davis, K Dobashi, ... Cell 58 (2), 287-292, 1989 | 440 | 1989 |
| Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. X Qian, CM LeVea, JK Freeman, WC Dougall, MI Greene Proceedings of the National Academy of Sciences 91 (4), 1500-1504, 1994 | 229 | 1994 |
| Characterization of HCT116 human colon cancer cells in an orthotopic model A Rajput, ID San Martin, R Rose, A Beko, C LeVea, E Sharratt, ... Journal of Surgical Research 147 (2), 276-281, 2008 | 191 | 2008 |
| Ligand and p185c-neu density govern receptor interactions and tyrosine kinase activation. A Samanta, CM LeVea, WC Dougall, X Qian, MI Greene Proceedings of the National Academy of Sciences 91 (5), 1711-1715, 1994 | 148 | 1994 |
| Significance of signet-ring cells in patients with colorectal cancer R Pande, A Sunga, C LeVea, GE Wilding, W Bshara, M Reid, MG Fakih Diseases of the colon & rectum 51 (1), 50-55, 2008 | 132 | 2008 |
| Congenital tuberculosis in a neonatal intensive care unit: case report, epidemiological investigation, and management of exposures LH Lee, CM LeVea, PS Graman Clinical infectious diseases 27 (3), 474-477, 1998 | 100 | 1998 |
| Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: a retrospective cohort study E Al-Sukhni, K Attwood, EM Gabriel, CM LeVea, K Kanehira, SJ Nurkin International Journal of Surgery 37, 42-49, 2017 | 89 | 2017 |
| Knockdown of Ron kinase inhibits mutant phosphatidylinositol 3-kinase and reduces metastasis in human colon carcinoma J Wang, A Rajput, JLC Kan, R Rose, XQ Liu, K Kuropatwinski, J Hauser, ... Journal of Biological Chemistry 284 (16), 10912-10922, 2009 | 89 | 2009 |
| Mutant PIK3CA-bearing colon cancer cells display increased metastasis in an orthotopic model XN Guo, A Rajput, R Rose, J Hauser, A Beko, K Kuropatwinski, C LeVea, ... Cancer research 67 (12), 5851-5858, 2007 | 87 | 2007 |
| Anti-receptor antibodies reverse the phenotype of cells transformed by two interacting proto-oncogene encoded receptor proteins. T Wada, JN Myers, Y Kokai, VI Brown, J Hamuro, CM LeVea, MI Greene Oncogene 5 (4), 489-495, 1990 | 79 | 1990 |
| Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review O Al Ustwani, J Lohr, G Dy, C LeVea, G Connolly, P Arora, R Iyer Journal of gastrointestinal oncology 5 (1), E30, 2014 | 77 | 2014 |
| CD24 expression is an independent prognostic marker in cholangiocarcinoma S Agrawal, BW Kuvshinoff, T Khoury, J Yu, MM Javle, C LeVea, J Groth, ... Journal of Gastrointestinal Surgery 11, 445-451, 2007 | 62 | 2007 |
| Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study S Samuel, S Mukherjee, N Ammannagari, VK Pokuri, B Kuvshinoff, ... PLoS One 13 (6), e0198809, 2018 | 55 | 2018 |
| PTP LAR expression compared to prognostic indices in metastatic and non-metastatic breast cancer CM LeVea, CT McGary, JR Symons, RA Mooney Breast cancer research and treatment 64, 221-228, 2000 | 55 | 2000 |
| Epidermal growth factor receptor-directed therapy in esophageal cancer AU Pande, RV Iyer, A Rani, S Maddipatla, GY Yang, CE Nwogu, JD Black, ... Oncology 73 (5-6), 281-289, 2008 | 53 | 2008 |
| Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. MM Javle, D Tan, J Yu, CM LeVea, F Li, BW Kuvshinoff, JF Gibbs Hepato-gastroenterology 51 (60), 1653-1657, 2004 | 45 | 2004 |
| Enhanced FGFR signalling predisposes pancreatic cancer to the effect of a potent FGFR inhibitor in preclinical models H Zhang, BL Hylander, C LeVea, EA Repasky, RM Straubinger, AA Adjei, ... British journal of cancer 110 (2), 320-329, 2014 | 44 | 2014 |
| Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma MG Fakih, K BullardDunn, GY Yang, L Pendyala, K Toth, C Andrews, ... International Journal of Radiation Oncology* Biology* Physics 72 (3), 650-657, 2008 | 44 | 2008 |
| A newly recognized entity: intraductal “oncocytic” papillary neoplasm of the pancreas S Jyotheeswaran, G Zotalis, P Penmetsa, CM Levea, LO Schoeniger, ... The American journal of gastroenterology 93 (12), 2539-2543, 1998 | 43 | 1998 |
| Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma ST Glenn, CA Jones, S Sexton, CM LeVea, SM Caraker, G Hajduczok, ... Oncogene 33 (50), 5706-5715, 2014 | 41 | 2014 |
mark greeneProfessor university of pennsylvaniaVerified email at reo.med.upenn.edu
